Suppr超能文献

经导管主动脉瓣置换术的电生理影响:发生率、结局和当前管理策略。

Electrophysiologic Implications of Transcatheter Aortic Valve Replacement: Incidence, Outcomes, and Current Management Strategies.

机构信息

Division of Cardiology, Section of Electrophysiology, University of Colorado, 12401 E. 17th Ave., MS B-136, Aurora, CO, 80045, USA.

Denver VA Medical Center, Denver, USA.

出版信息

Curr Cardiol Rep. 2021 Oct 1;23(11):167. doi: 10.1007/s11886-021-01599-9.

Abstract

PURPOSE OF REVIEW

Transcatheter aortic valve replacement (TAVR) has changed the paradigm for management of severe aortic stenosis. Despite substantial procedural advancements, conduction system abnormalities remain a common complication following TAVR. In this review, we describe (1) incidence and risk factors for the development of conduction disturbances following TAVR, along with their prognostic significance, (2) the incidence and prognostic significance of new-onset arrhythmias following TAVR, (3) approach to management of perioperative and post-procedural conduction disturbances and arrhythmias, and (4) novel areas of research.

RECENT FINDINGS

Conduction disturbances including left bundle branch block (LBBB) and high-grade atrioventricular block (HAVB) remain common issues post-TAVR despite advancements in valve technology and improvements in procedural technique. Despite data showing most conduction abnormalities resolve over time, rates of post-procedural permanent pacemaker implantation remain high. Similarly, rates of new-onset or newly detected arrhythmia, particularly atrial fibrillation, have been widely reported post-implantation of all types of TAVR valves. Recent consensus statements and decision pathway documents have been helpful in standardizing an approach to post-TAVR conduction disturbances. New areas of research show promise both for predicting which patients will develop conduction disturbances post-TAVR and for management of HAVB with novel pacing techniques. On the other hand, management of new-onset or newly detected atrial fibrillation after TAVR remains a significant challenge without standardized treatment strategy.

摘要

目的综述

经导管主动脉瓣置换术(TAVR)改变了严重主动脉瓣狭窄的治疗模式。尽管手术技术取得了重大进展,但传导系统异常仍然是 TAVR 后的常见并发症。在这篇综述中,我们描述了(1)TAVR 后发生传导障碍的发生率和危险因素,以及它们的预后意义,(2)TAVR 后新发心律失常的发生率和预后意义,(3)围手术期和术后传导障碍和心律失常的处理方法,以及(4)新的研究领域。

最近的发现

尽管瓣膜技术的进步和手术技术的改进,传导障碍(包括左束支传导阻滞(LBBB)和高度房室传导阻滞(HAVB))仍然是 TAVR 后常见的问题。尽管数据显示大多数传导异常随时间逐渐缓解,但术后永久性起搏器植入的发生率仍然很高。同样,各种 TAVR 瓣膜植入后新发或新发现的心律失常(特别是心房颤动)的发生率也被广泛报道。最近的共识声明和决策路径文件有助于规范 TAVR 后传导障碍的处理方法。新的研究领域在预测哪些患者会在 TAVR 后发生传导障碍以及使用新型起搏技术治疗 HAVB 方面显示出了希望。另一方面,在没有标准化治疗策略的情况下,TAVR 后新发或新发现的心房颤动的管理仍然是一个重大挑战。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验